Shu Xia

1.7k total citations
56 papers, 673 citations indexed

About

Shu Xia is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Shu Xia has authored 56 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Shu Xia's work include Lung Cancer Treatments and Mutations (10 papers), Allergic Rhinitis and Sensitization (8 papers) and Asthma and respiratory diseases (8 papers). Shu Xia is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Allergic Rhinitis and Sensitization (8 papers) and Asthma and respiratory diseases (8 papers). Shu Xia collaborates with scholars based in China, United States and Australia. Shu Xia's co-authors include Chao Zhuo, Meijun Du, Liang Wang, Rachel L. Dittmar, Shiying Yu, Chiang‐Ching Huang, Liang Zhuang, Man Zou, Tiezheng Yuan and Yingchun Xu and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Shu Xia

53 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu Xia China 15 228 171 159 148 107 56 673
Xiaotian Dai China 13 145 0.6× 327 1.9× 117 0.7× 90 0.6× 96 0.9× 29 594
Dorota Pastuszak‐Lewandoska Poland 18 145 0.6× 321 1.9× 159 1.0× 159 1.1× 34 0.3× 72 790
Yulong Zheng China 15 83 0.4× 367 2.1× 260 1.6× 75 0.5× 77 0.7× 29 580
Luo Yang China 14 152 0.7× 260 1.5× 133 0.8× 105 0.7× 22 0.2× 43 615
Adam Gilbertsen United States 13 223 1.0× 223 1.3× 77 0.5× 21 0.1× 34 0.3× 26 528
Qingting Wang China 17 293 1.3× 383 2.2× 139 0.9× 59 0.4× 19 0.2× 50 803
Florian Brockhaus United States 13 589 2.6× 204 1.2× 31 0.2× 50 0.3× 93 0.9× 21 1.0k

Countries citing papers authored by Shu Xia

Since Specialization
Citations

This map shows the geographic impact of Shu Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Xia more than expected).

Fields of papers citing papers by Shu Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Xia. The network helps show where Shu Xia may publish in the future.

Co-authorship network of co-authors of Shu Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Xia. A scholar is included among the top collaborators of Shu Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Xia. Shu Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yang, Xiangsheng, Chunrong Ju, Yijing Chen, et al.. (2024). Overexpression of STX11 alleviates pulmonary fibrosis by inhibiting fibroblast activation via the PI3K/AKT/mTOR pathway. Signal Transduction and Targeted Therapy. 9(1). 306–306. 14 indexed citations
3.
4.
Lou, Liang, Chengjun Zhu, Peng Chen, et al.. (2024). Rationally designed BCR-ABL kinase inhibitors for improved leukemia treatment via covalent and pro-/dual-drug targeting strategies. Journal of Advanced Research. 74. 541–554. 2 indexed citations
5.
Qian, Weiping, Shu Xia, Xiaoyun Yang, et al.. (2022). Complex Involvement of the Extracellular Matrix, Immune Effect, and Lipid Metabolism in the Development of Idiopathic Pulmonary Fibrosis. Frontiers in Molecular Biosciences. 8. 800747–800747. 17 indexed citations
6.
Zhu, Zheng, Hongyu Wang, Yanqing Xie, et al.. (2021). Response of upper and lower airway inflammation to bronchial challenge with house dust mite in Chinese asthmatics: a pilot study. Journal of Thoracic Disease. 13(8). 4988–4998. 2 indexed citations
7.
8.
Xia, Shu, Bingpeng Guo, Weiping Qian, et al.. (2020). Ultra-low dose rituximab as add-on therapy in anti-MDA5-positive patients with polymyositis /dermatomyositis associated ILD. Respiratory Medicine. 172. 105983–105983. 23 indexed citations
9.
Guo, Bingpeng, Shu Xia, Weiping Qian, et al.. (2020). The interstitial lung disease spectrum under a uniform diagnostic algorithm: a retrospective study of 1,945 individuals. Journal of Thoracic Disease. 12(7). 3688–3696. 15 indexed citations
10.
Xu, Fei, Xiaoli Ren, Yuan Chen, et al.. (2019). Progress in the diagnosis and treatment of extensive-stage small cell lung cancer. Oncology and Translational Medicine. 5(1). 33–42. 1 indexed citations
11.
Li, Jing, Peng Peng, Qi Mei, et al.. (2018). The impact of UGT2B7 C802T and CYP3A4*1G polymorphisms on pain relief in cancer patients receiving oxycontin. Supportive Care in Cancer. 26(8). 2763–2767. 9 indexed citations
12.
Liu, Yang, Shu Xia, Timothy Kudinha, et al.. (2017). Prevalence of ST1193 clone and IncI1/ST16 plasmid in E-coli isolates carrying blaCTX-M-55 gene from urinary tract infections patients in China. Scientific Reports. 7(1). 44866–44866. 45 indexed citations
13.
Zhu, Zheng, Yanqing Xie, Wei‐jie Guan, et al.. (2017). Effects of leukotriene D4 nasal challenge on bronchial responsiveness and inflammation in asthmatic patients with allergic rhinitis. Journal of Thoracic Disease. 9(2). 271–277. 2 indexed citations
14.
Zhu, Zheng, Yanqing Xie, Wei‐jie Guan, et al.. (2016). Leukotriene D4 nasal provocation test: Rationale, methodology and diagnostic value. Experimental and Therapeutic Medicine. 12(1). 525–529. 2 indexed citations
15.
Xiao, Xiaoguang, Shujing Wang, Shu Xia, et al.. (2015). Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung cancer. OncoTargets and Therapy. 8. 2209–2209. 12 indexed citations
16.
Xi, Qingsong, et al.. (2013). Development and validation of a prognostic scale for hospitalized patients with terminally ill cancer in China. Supportive Care in Cancer. 22(1). 145–152. 9 indexed citations
17.
Gui, Qi, Chengcheng Xu, Liang Zhuang, et al.. (2013). A new rat model of bone cancer pain produced by rat breast cancer cells implantation of the shaft of femur at the third trochanter level. Cancer Biology & Therapy. 14(2). 193–199. 17 indexed citations
18.
Xia, Shu, et al.. (2010). Inhibiting PI3K/Akt pathway increases DNA damage of cervical carcinoma HeLa cells by drug radiosensitization. Journal of Huazhong University of Science and Technology [Medical Sciences]. 30(3). 360–364. 6 indexed citations
19.
Xia, Shu, Shiying Yu, & Xianglin Yuan. (2005). Expression of Hypoxia Inducible Factor 1α and Its Significance in Non-small Cell Lung Cancer. The Chinese-German Journal of Clinical Oncology. 4(5). 284–286.
20.
Xiong, Huihua, et al.. (2005). Expression of Survivin, Mutant p53 and C-erbB-2 in Breast Cancer and Its Clinical Significance. The Chinese-German Journal of Clinical Oncology. 4(4). 229–231. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaotian Dai Breakdown of academic impact, for papers by Dorota Pastuszak‐Lewandoska Breakdown of academic impact, for papers by Yulong Zheng Breakdown of academic impact, for papers by Luo Yang Breakdown of academic impact, for papers by Adam Gilbertsen Breakdown of academic impact, for papers by Qingting Wang Breakdown of academic impact, for papers by Florian Brockhaus
Rankless by CCL
2026